SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Renovar Regulatory News (MRV)

Share Price Information for Maven Renovar (MRV)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
53.00
Ask:
53.50
Spread: 0.50 (0.943%)
Market Cap: £68.50m
MRV Live PriceLast checked at - London Stock Exchange

Intraday Maven Renovar Share Chart

Receipt of Requisition Request

1 Jul 2025 07:00

RNS Number : 1607P
Maven Renovar VCT PLC
01 July 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

1 July 2025

 

Maven Renovar VCT PLC (the "Company")

 

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Receipt of Requisition Request

 

The board of directors (the "Board") of the Company announces that it has received a letter from Paul Jourdan, shareholder and former manager of the Company's portfolio, and a group of other shareholders seeking to convene a general meeting of the Company (the "Requisition") to consider ordinary resolutions to remove the current Board and appoint four replacement directors, including Paul Jourdan, in their place.

Following the Company's annual general meeting on 19 June 2025, the Board is undertaking a process to understand shareholder concerns and make recommendations to shareholders. This process is led by Robert Legget, a recently appointed independent non-executive director of the Company and chair of the Board's nomination committee. The Board is reviewing the legal validity of the Requisition with its advisers and will make further announcements regarding the convening of a general meeting in due course.

The Board remains committed to acting in the best interests of all Shareholders and, having undertaken a thorough and independent assessment of the Company's management arrangements as part of the strategic review process, the Board is confident that the Company's new investment manager, Maven Capital Partners UK LLP ("Maven") has the skills and resources required to support the management of the Company's portfolio going forward. Maven has an experienced and competent team who focus on AIM investments and, having taken over the management of the portfolio on 1 May 2025, the team has carried out extensive due diligence on the Company's portfolio and is familiar with each investment in the portfolio and the performance/risks associated therewith. Maven will continue to manage the portfolio in accordance with the Company's current investment objectives and policy throughout the Requisition process.

With respect to the Requisition, the Board recommends that Shareholders take no action at this time and await further announcement from the Company which will be made in due course.

 

Enquiries:

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGGNKMMGKZG
Date   Source Headline
12th Jun 20264:42 pmRNSUnaudited Net Asset Value
10th Jun 20265:02 pmRNSTransaction in Own Shares
8th Jun 20269:24 amRNSUnaudited Net Asset Value
4th Jun 20261:24 pmRNSTransaction in Own Shares
2nd Jun 202612:05 pmRNSUnaudited Net Asset Value
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20264:27 pmRNSTransaction in Own Shares
26th May 20261:50 pmRNSResult of Tender Offer
26th May 202611:29 amRNSUnaudited Net Asset Value
22nd May 202610:56 amRNSTransaction in Own Shares
20th May 20264:30 pmRNSAnnual Financial Report
20th May 20263:25 pmRNSResult of General Meeting
18th May 20262:52 pmRNSUnaudited Net Asset Value
14th May 202610:52 amRNSTransaction in Own Shares
11th May 202612:24 pmRNSUnaudited Net Asset Value
6th May 202612:54 pmRNSTransaction in Own Shares
1st May 20264:28 pmRNSUnaudited Net Asset Value
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20264:49 pmRNSUnaudited Net Asset Value
27th Apr 202610:02 amRNSPublication of Tender Offer Circular
23rd Apr 20262:12 pmRNSTransaction in Own Shares
17th Apr 20264:02 pmRNSUnaudited Net Asset Value
13th Apr 202612:36 pmRNSUnaudited Net Asset Value
2nd Apr 20269:02 amRNSUnaudited Net Asset Value
2nd Apr 20267:00 amRNSTender Offer
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20262:48 pmRNSTransaction in Own Shares
27th Mar 20264:17 pmRNSUnaudited NAV
27th Mar 20267:00 amRNSDividend Declaration
23rd Mar 202612:14 pmRNSUnaudited NAV
19th Mar 20264:14 pmRNSTransaction in Own Shares
18th Mar 20262:53 pmRNSCompliance with Market Abuse Regulation
16th Mar 20264:10 pmRNSUnaudited Net Asset Value
12th Mar 202611:49 amRNSTransaction in Own Shares
9th Mar 202612:37 pmRNSTransaction in Own Shares
9th Mar 202610:20 amRNSUnaudited Net Asset Value
3rd Mar 20261:01 pmRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSUnaudited Net Asset Value
23rd Feb 20263:53 pmRNSTransaction in Own Shares
23rd Feb 202610:35 amRNSUnaudited Net Asset Value
19th Feb 202612:05 pmRNSTransaction in Own Shares
13th Feb 20263:08 pmRNSUnaudited Net Asset Value
10th Feb 202612:15 pmRNSTransaction in Own Shares
10th Feb 202612:12 pmRNSStatement re Provision 5.2.4 of the AIC Code
6th Feb 20264:42 pmRNSUnaudited Net Asset Value
3rd Feb 20262:42 pmRNSTransaction in Own Shares
3rd Feb 202611:41 amRNSUnaudited Net Asset Value
2nd Feb 20267:00 amRNSChange of Company Secretary and Registered Office
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20262:36 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.